Skip to main content
. Author manuscript; available in PMC: 2022 Oct 13.
Published in final edited form as: Neuroscience. 2020 Jul 9;442:183–192. doi: 10.1016/j.neuroscience.2020.07.006

Figure 5.

Figure 5.

No Increase in Caspase-3 Activation or GFAP Expression. (5A) Confocal fluorescent micrographs demonstrating dopaminergic neurons expressing EYFP-P2A-C3 and EYFP did not show any appreciable caspase 3 activation. (5B) Micrographs demonstrating visualization of GFAP without change in comparison to both controls and non-injected side in each animal. Moreover, expression was seen primarily in the substantia nigra pars reticulata, not in the SNc. Scale bars: A) 10 μm; B) 10 μm.